Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ProPhase Labs Inc
PRPHCurrent price
0.78 USD
+0.0069 USD (+0.90%)
Last closed
0.77 USD
Company
www.prophaselabs.com
ISIN
US74345W1080
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Capitalization
18 798 388 USD
Yield for 12 month
-82.54 %
1Y
3Y
5Y
10Y
15Y
PRPH
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York. Address: 711 Stewart Avenue, Garden City, NY, United States, 11530
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
18.5 USDP/E ratio
–Dividend Yield
–Current Year
+44 384 000 USD
Last Year
+122 647 000 USD
Current Quarter
+3 146 000 USD
Last Quarter
+2 474 000 USD
Current Year
+16 239 000 USD
Last Year
+70 654 000 USD
Current Quarter
-165 000 USD
Last Quarter
-476 000 USD
Key Figures PRPH
1 year
3 years
5 years
10 years
EBITDA
-27 014 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-22.98 %
PEG Ratio
–
Return On Equity TTM
-50.92 %
Wall Street Target Price
18.5 USD
Revenue TTM
17 972 000 USD
Book Value
2.74 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-81.3 %
Dividend Yield
–
Gross Profit TTM
70 654 000 USD
Earnings per share
-1.48 USD
Diluted Eps TTM
-1.48 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-95.2 %
Profit Margin
-146.39 %
Dividend Analytics PRPH
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
-14 %Dividend History PRPH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
24.05.2022
Forward Annual Dividend Yield
–
Last Split Factor
2:1
Payout Ratio
–
Last Split Date
23.01.1997
Dividend Date
03.06.2022
Stock Valuation PRPH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
10.0908
Enterprise Value Revenue
2.3894
Price Sales TTM
1.046
Enterprise Value EBITDA
2.4498
Price Book MRQ
0.4062
Financials PRPH
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PRPH
For 52 weeks
0.66 USD
7.48 USD
50 Day MA
2.16 USD
Shares Short Prior Month
206 120
200 Day MA
3.9 USD
Short Ratio
7.04
Shares Short
154 056
Short Percent
0.97 %
BeatStart